Literature DB >> 2230271

Transmission of Chlamydia pneumoniae in young children in a Japanese family.

T Yamazaki1, H Nakada, N Sakurai, C C Kuo, S P Wang, J T Grayston.   

Abstract

Chlamydia pneumoniae strain TWAR was isolated from the respiratory tract of a 5-year-old girl suffering from pneumonia. The IgM and IgG antibody titers to TWAR were 1:32 and 1:128, respectively. Cultures and serology for other common bacterial and viral respiratory pathogens were negative. Although she was treated with 35 mg/kg/day rokitamycin, TWAR was repeatedly isolated after treatment. Her 3-year-old sister developed acute bronchitis, and TWAR was isolated from her nasopharynx. She was treated with 43 mg/kg/day erythromycin with prompt improvement, and TWAR was not isolated after treatment. Although her mother, grandmother, and 8-month-old sister suffered from respiratory illness during these periods, TWAR was not isolated from them. The repeated isolations from the index patient suggest that infection was transmitted from sister to sister. This case represents the first reported isolation of TWAR from young children in the same household and the first from Japan.

Entities:  

Mesh:

Year:  1990        PMID: 2230271     DOI: 10.1093/infdis/162.6.1390

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  The Role of Chlamydia in Upper Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

Review 2.  Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis.

Authors:  S J Bourke; N F Lightfoot
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

3.  Polymerase chain reaction for detection of Chlamydia pneumoniae in gargled-water specimens of children.

Authors:  P M Prückl; C Aspöck; A Makristathis; M L Rotter; H Wank; B Willinger; A M Hirschl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

4.  Chlamydia pneumoniae.

Authors:  T J Marrie
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

5.  Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.

Authors:  K Nakata; Y Okazaki; H Hattori; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

6.  Factors influencing the infectivity of Chlamydia pneumoniae elementary bodies on HL cells.

Authors:  J J Theunissen; B Y van Heijst; J H Wagenvoort; E Stolz; M F Michel
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

7.  Chlamydia pneumoniae pneumonia: An evolving clinical spectrum.

Authors:  D Megran; R W Peeling; T J Marrie
Journal:  Can J Infect Dis       Date:  1995-07

8.  In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.

Authors:  C C Kuo; L A Jackson; A Lee; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 9.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

10.  Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol.

Authors:  S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.